Skip to main content

Acute Care for Cannabis Use Increases Risk for Subsequent New Dementia Diagnosis

Medically reviewed by Carmen Pope, BPharm. Last updated on April 18, 2025.

By Lori Solomon HealthDay Reporter

FRIDAY, April 18, 2025 -- Individuals seeking acute care for cannabis use have an increased risk for a new dementia diagnosis compared with those with all-cause hospital-based care or the general population, according to a study published online April 14 in JAMA Neurology.

Daniel T. Myran, M.D., M.P.H., from the University of Ottawa in Ontario, Canada, and colleagues investigated the association between emergency department visits or hospitalizations (acute care encounters) due to cannabis and future dementia diagnosis. The analysis included health administrative data from 6 million individuals (aged 45 to 105 years living in Ontario between 2008 and 2021) without a diagnosis of dementia at baseline.

The researchers found that annual rates of incident acute care due to cannabis use increased fivefold in individuals aged 45 to 64 years (from 10.16 to 50.65 per 100,000) and increased 26.7-fold in individuals aged 65 years and older (from 0.65 to 16.99 per 100,000) during the study period. Individuals with incident acute care due to cannabis use had a 1.5-fold and 3.9-fold increased five-year risk for dementia diagnosis versus individuals with all-cause acute care and the general population of matched adults (absolute rates of dementia diagnosis: 5.0 percent for cannabis-related acute care, 3.6 percent for all-cause acute care, and 1.3 percent in the general population). Individuals with acute care due to cannabis use remained at elevated risk relative to those with all-cause acute care (adjusted hazard ratio [aHR], 1.23) and the general population (aHR, 1.72) when adjusting for sociodemographic factors and chronic health conditions. However, dementia risk was lower for individuals with acute care due to cannabis use than those with acute care due to alcohol use (aHR, 0.69).

"These findings have important implications considering increasing cannabis use among older adults," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted April 2025

Read this next

Moderately Preterm Birth Tied to Long-Term Cognitive Problems

FRIDAY, April 25, 2025 -- Moderately preterm birth is associated with cognitive problems at ages 9 to 10 years, according to a study published online April 14 in JAMA Network...

Metabolic Syndrome Linked to Increased Risk for Young-Onset Dementia

THURSDAY, April 24, 2025 -- Metabolic syndrome (MetS) and its individual components are associated with an increased risk for young-onset dementia (YOD), according to a study...

Dementia Biomarkers Associated With Age, Sex, APOE ε4 Status

MONDAY, April 21, 2025 -- Dementia biomarkers -- phosphorylated tau (P-tau181), neurofilament light (NfL), and glial fibrillary acidic protein (GFAP) -- are associated with age...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.